Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 128 (1) , 130-137
- https://doi.org/10.1016/j.jtcvs.2003.11.061
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 casesThe Annals of Thoracic Surgery, 1997
- Prognosis of unsuspected but completely resectable N2 non-small cell lung cancerThe Annals of Thoracic Surgery, 1993
- Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchusEuropean Journal of Cardio-Thoracic Surgery, 1990
- The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lungThe Journal of Thoracic and Cardiovascular Surgery, 1990
- A New International Staging System for Lung CancerChest, 1986
- Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node MetastasesAnnals of Surgery, 1983
- Clinical Staging of Primary Lung CancerAmerican Review of Respiratory Disease, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958